Britain pledges $485 mln to global vaccine project
LECCE, Italy (Reuters) - Britain will invest almost $500 million in an international scheme to encourage pharmaceutical firms to develop vaccines against some of the common diseases which plague poorer nations.
The Advance Market Commitment, a pilot project launched on the sidelines of the G8 finance ministers meeting this weekend, guarantees to buy vaccines at fixed prices once they have been developed, giving drug companies an incentive to produce them.
"The UK is pleased to support this initiative ... which should ensure a sustainable and affordable supply of vaccines well into the future," said British finance minister Alistair Darling.
Britain, Italy, Canada, Russia, Norway and the Bill and Melinda Gates Foundation are investing a total of $1.5 billion in the project, which is being run by the World Bank, UNICEF, the World Health Organization and the international vaccine agency GAVI alliance.
Pharmaceutical firms who sign up will be tasked with developing vaccines to fight pneumococcal diseases, which claim up to 1.6 million lives each year -- most of them children.
Firms that participate will also make legally binding commitments to supply the vaccines at lower and sustainable prices after the donor funds are spent.
The AMC scheme aims to prevent more than 7 million deaths by 2030.
© Thomson Reuters 2009 All rights reserved
One Year Later
A year after militants laid siege to Mumbai, the country still remains very vulnerable. Full Article | Full Coverage
Liberhan Commission Report
The government published a long awaited report, recently leaked, accusing BJP leaders of a role in the 1992 destruction of the Babri mosque in Ayodhya. Full Article
